• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Targeting PI3K/AKT/mTOR pathway in platinum-resistant ovarian high-grade serous carcinoma: Translational analysis from the randomized phase II OCTOPUS trial

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Giannone, G.
    Ennis, D.
    Mirza, H. B.
    Cheng, Z.
    McDermott, J.
    Lewsley, L. A.
    Clamp, Andrew R
    Herbertson, R. A.
    Glasspool, R. M.
    Krell, J.
    Hinsley, S.
    Banerji, U.
    Riisnaes, R.
    Banerjee, S.
    McNeish, I.
    Show allShow less
    Affiliation
    Surgery and Cancer, Imperial College London - Hammersmith Campus, London,
    Issue Date
    2022
    
    Metadata
    Show full item record
    Abstract
    Background: In arm 1 of the phase II randomised OCTOPUS trial (ISRCTN16426935), no significant differences in Progression-Free Survival (PFS) or Overall Survival were observed with the addition of vistusertib (V), a dual mTORC1/2 inhibitor, to weekly paclitaxel (wP) in platinum-resistant/refractory ovarian high-grade serous carcinoma. However, preliminary immunohistochemistry (IHC) data suggested that PTEN status may be predictive of benefit of addition of V to wP. Aim: We evaluated if PTEN expression (scored using quantitative digital IHC) or specific genomic features might be predictive of V benefit. We also compared genomic profiles in archival and study entry specimens. Methods: PTEN expression in archival samples (N¼68) was scored using QuPath Histo-score (H-score; range 0-300), and compared to pathologist scoring. In archival (N¼43) and study entry (N¼35) samples, DNA copy number (CN) and CN signature exposure were assessed using shallow whole genome sequencing; target sequencing was performed using a custom panel (Illumina AmpliSeq). Results: Digital quantification of PTEN status was feasible with a high correlation between QuPath and pathologist scores (r¼0.94, p<0.0001 for tumour; r¼0.70, p¼0.009 for non-tumour). H-score variability was lower in non-tumour than in tumour cells. Patients with low PTEN tumours (defined as tumour<non-tumour H score) showed a longer PFS compared with those with PTEN proficient (tumour non tumour H-score) in the V+wP arm [respectively 9.4 vs 4.1 months (mo) p¼0.003] but not in the wP arm (4.8 vs 4.2 mo p¼0.60). There was no difference in overall ploidy, rates of focal somatic CN alterations or CN signature exposure between diagnosis and relapse. However, high exposure to CN signature 4 (defined as median signature 4 exposure across all samples) appeared associated with longer PFS (5.4 vs 3.3 mo p¼0.125) in the V+wP arm but worse outcome in the wP arm (2.3 vs 4.6 mo p¼0.018). Conclusions: PTEN loss by IHC and high exposure to CN signature 4 both appear to be associated with longer PFS in patients treated with V+wP. Validation in further sample sets will be required.
    Citation
    Giannone G, Ennis D, Mirza HB, Cheng Z, McDermott J, Lewsley LA, et al. Targeting PI3K/AKT/mTOR pathway in platinum-resistant ovarian high-grade serous carcinoma: Translational analysis from the randomized phase II OCTOPUS trial. Annals of Oncology. 2022 Jun;33:S384-S. PubMed PMID: WOS:000814982500005.
    Journal
    Annals of Oncology
    URI
    http://hdl.handle.net/10541/625476
    Type
    Meetings and Proceedings
    Language
    en
    Collections
    All Christie Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.